SCHEMBL3961942

SCHEMBL3961942

NC(=O)CCNc1ncc(Cl)c(-c2cc3c(C(=O)NC4CC4)cccc3s2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.38
DYRK1A Q13627 2/20 0.37
DYRK1B Q9Y463 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
AXL P30530 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CHEK1 O14757 3/20 0.36
TYRO3 Q06418 3/20 0.36
CSNK2A1 P68400 2/20 0.36
SELP P16109 2/20 0.36
IKBKB O14920 1/20 0.36
AURKA O14965 1/20 0.36
PAK4 O96013 1/20 0.36
CHEK2 O96017 1/20 0.36
ABL1 P00519 1/20 0.36
EGFR P00533 1/20 0.36
INSR P06213 1/20 0.36
LCK P06239 1/20 0.36
FGFR1 P11362 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3961953 0.90 CCNT1 (0.39) P2RX7NPC1RAB9AAXLL3MBTL1
Hydrochloric Acid SCHEMBL3963698 0.88 AXL (0.38) P2RX7NPC1RAB9AAXLL3MBTL1
SCHEMBL3961504 0.85 TYRO3 (0.40) P2RX7NPC1RAB9AAXLCHEK1
SCHEMBL3969558 0.85 TYRO3 (0.36) AXLCHEK1TYRO3CSNK2A1SELP
SCHEMBL4209762 0.85 FGFR1 (0.39) AXLCHEK1TYRO3CSNK2A1SELP
Hydrochloric Acid SCHEMBL3967274 0.85 AXL (0.47) AXLCHEK1TYRO3CSNK2A1SELP
Hydrochloric Acid SCHEMBL3966674 0.85 TYRO3 (0.40) P2RX7NPC1RAB9AAXLCHEK1
SCHEMBL3966655 0.85 FGFR1 (0.39) AXLCHEK1TYRO3CSNK2A1SELP
Hydrochloric Acid SCHEMBL3970787 0.84 FGFR1 (0.43) AXLCHEK1TYRO3CSNK2A1SELP
SCHEMBL3972472 0.84 KDM1A (0.40) AXLCHEK1TYRO3CDK2CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed
US-7547691-B2 [4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases ELI LILLY AND COMPANY (US) 2009-06-16 US disclosed
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases ELI LILLY AND COMPANY 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases NFKBIA, IKBKB, IKBKG P2RX7 1253/4885DYRK1A 2680/4885DYRK1B 1957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.